Chad Messer
Stock Analyst at Lake Street
(0.45)
# 4,188
Out of 4,854 analysts
24
Total ratings
29.17%
Success rate
-26.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BOLT Bolt Biotherapeutics | Initiates: Buy | $4 | $0.32 | +1,138.39% | 1 | May 20, 2025 | |
| LTRN Lantern Pharma | Initiates: Buy | $25 | $3.32 | +653.01% | 1 | Apr 2, 2025 | |
| IMNM Immunome | Initiates: Buy | $23 | $9.13 | +151.92% | 1 | Apr 2, 2025 | |
| OSTX OS Therapies | Initiates: Buy | $19 | $1.67 | +1,037.72% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $1.22 | +9,244.26% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $13.07 | +282.70% | 1 | Jul 27, 2021 | |
| CYTK Cytokinetics | Maintains: Buy | $33 → $48 | $32.30 | +48.61% | 2 | Jul 19, 2021 | |
| EXEL Exelixis | Maintains: Buy | $33 → $30 | $43.03 | -30.28% | 3 | Jun 28, 2021 | |
| RNA Avidity Biosciences | Initiates: Buy | $50 | $36.24 | +37.97% | 1 | Jun 17, 2021 | |
| CRMD CorMedix | Maintains: Buy | $31 → $29 | $13.98 | +107.44% | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.74 | +264.96% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $35.29 | +143.70% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $2.45 | +2,961.22% | 1 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $12.78 | +244.29% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $43.01 | +285.96% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $3.97 | +353.40% | 1 | May 5, 2020 |
Bolt Biotherapeutics
May 20, 2025
Initiates: Buy
Price Target: $4
Current: $0.32
Upside: +1,138.39%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $3.32
Upside: +653.01%
Immunome
Apr 2, 2025
Initiates: Buy
Price Target: $23
Current: $9.13
Upside: +151.92%
OS Therapies
Apr 2, 2025
Initiates: Buy
Price Target: $19
Current: $1.67
Upside: +1,037.72%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $1.22
Upside: +9,244.26%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $13.07
Upside: +282.70%
Cytokinetics
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $32.30
Upside: +48.61%
Exelixis
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $43.03
Upside: -30.28%
Avidity Biosciences
Jun 17, 2021
Initiates: Buy
Price Target: $50
Current: $36.24
Upside: +37.97%
CorMedix
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $13.98
Upside: +107.44%
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $2.74
Upside: +264.96%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $35.29
Upside: +143.70%
Mar 15, 2021
Initiates: Buy
Price Target: $75
Current: $2.45
Upside: +2,961.22%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $12.78
Upside: +244.29%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $43.01
Upside: +285.96%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $3.97
Upside: +353.40%